Roch P. Boivin
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 2
- Genetics top 5%
- Estrogen and related hormone effects 14
-
- Hormonal Regulation and Hypertension 5
- Hormonal and reproductive studies 3
- Pharmacology top 10%
- Synthesis of Organic Compounds 2
-
- Steroid Chemistry and Biochemistry 12
- Glycosylation and Glycoproteins Research 1
-
- Catalytic C–H Functionalization Methods 1
- Co-authors
- Donald PoirierVan Luu‐TheMartin TremblayFernand LabrieSheng‐Xiang LinLiviu C. CiobanuWei QiuRoger Lachance
- Journals
- The FASEB Journal (1 paper)Journal of Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- CanadaUnited StatesRussia
In The Last Decade
Roch P. Boivin
17 papers receiving 642 citations
Peers
Comparison fields: 5 of 65
- Toxicology 64
- Genetics 384
- Endocrinology, Diabetes and Metabolism 184
- Pharmacology 54
- Molecular Biology 406
Countries citing papers authored by Roch P. Boivin
This map shows the geographic impact of Roch P. Boivin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roch P. Boivin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roch P. Boivin more than expected).
Fields of papers citing papers by Roch P. Boivin
This network shows the impact of papers produced by Roch P. Boivin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roch P. Boivin. The network helps show where Roch P. Boivin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roch P. Boivin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 31 | |
| 2 | 2009 | 85 | |
| 3 | 2005 | 25 | |
| 4 | 2005 | 34 | |
| 5 | 2005 | 51 | |
| 6 | 2003 | 23 | |
| 7 | 2003 | 18 | |
| 8 | 2002 | 81 | |
| 9 | 2001 | 23 | |
| 10 | 2000 | 79 | |
| 11 | 1999 | 17 | |
| 12 | 1999 | 71 | |
| 13 | 1999 | 21 | |
| 14 | 1998 | 42 | |
| 15 | 1998 | 1 | |
| 16 | C16 and C17 derivatives of estradiol as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1: chemical synthesis and structure-activity relationships. | 1998 | 41 |
| 17 | 1994 | 16 |
About Roch P. Boivin
Roch P. Boivin is a scholar working on Toxicology, Genetics and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 659 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (14 papers), Steroid Chemistry and Biochemistry (12 papers), Hormonal Regulation and Hypertension (5 papers), Hormonal and reproductive studies (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Synthesis of Organic Compounds (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Catalytic C–H Functionalization Methods (1 paper). The work is most often cited by research in Toxicology (64 citations), Genetics (384 citations) and Endocrinology, Diabetes and Metabolism (184 citations). Roch P. Boivin has collaborated with scholars based in Canada, United States and Russia. Frequent co-authors include Donald Poirier, Van Luu‐The, Martin Tremblay, Fernand Labrie, Sheng‐Xiang Lin, Liviu C. Ciobanu, Wei Qiu, Roger Lachance, Marie Bérubé and Serge Auger. Their work appears in journals such as The FASEB Journal, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.